Fondazione IRCCS Istituto Nazionale dei Tumori Researcher Adds New Data to Research in Lymphoma (Monocytes in leukapheresis products affect the outcome of CD19-targeted CAR T-cell therapy in lymphoma patients).

MLA

“Fondazione IRCCS Istituto Nazionale Dei Tumori Researcher Adds New Data to Research in Lymphoma (Monocytes in Leukapheresis Products Affect the Outcome of CD19-Targeted CAR T-Cell Therapy in Lymphoma Patients).” Cancer Gene Therapy Week, Mar. 2024, p. 13. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=175769795&authtype=sso&custid=ns315887.

APA

Fondazione IRCCS Istituto Nazionale dei Tumori Researcher Adds New Data to Research in Lymphoma (Monocytes in leukapheresis products affect the outcome of CD19-targeted CAR T-cell therapy in lymphoma patients). (2024). Cancer Gene Therapy Week, 13.

Chicago

“Fondazione IRCCS Istituto Nazionale Dei Tumori Researcher Adds New Data to Research in Lymphoma (Monocytes in Leukapheresis Products Affect the Outcome of CD19-Targeted CAR T-Cell Therapy in Lymphoma Patients).” 2024. Cancer Gene Therapy Week, March, 13. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=175769795&authtype=sso&custid=ns315887.